InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
0.8800
+0.0414 (4.94%)
At close: Feb 20, 2026, 4:00 PM EST
0.8976
+0.0176 (2.00%)
After-hours: Feb 20, 2026, 4:10 PM EST
InterCure Market Cap
InterCure has a market cap or net worth of $48.97 million as of February 20, 2026. Its market cap has decreased by -36.27% in one year.
Market Cap
48.97M
Enterprise Value
90.30M
1-Year Change
-36.27%
Ranking
Category
Stock Price
$0.88
Market Cap Chart
Since December 16, 2010, InterCure's market cap has increased from $1.78M to $48.97M, an increase of 2,649.22%. That is a compound annual growth rate of 24.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 48.97M | -11.78% |
| Dec 31, 2025 | 55.50M | -25.61% |
| Dec 31, 2024 | 74.61M | 27.32% |
| Dec 31, 2023 | 58.60M | -62.52% |
| Dec 29, 2022 | 156.35M | -47.90% |
| Dec 30, 2021 | 300.11M | 119.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Incannex Healthcare | 103.34M |
| Citius Oncology | 100.63M |
| Assertio Holdings | 75.11M |
| Cumberland Pharmaceuticals | 57.88M |
| Zhengye Biotechnology Holding | 41.70M |
| Rockwell Medical | 38.22M |
| Talphera | 35.96M |
| BioXcel Therapeutics | 34.12M |